These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26400151)

  • 1. Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV.
    Carmo RF; Aroucha D; Vasconcelos LR; Pereira LM; Moura P; Cavalcanti MS
    J Viral Hepat; 2016 Feb; 23(2):116-22. PubMed ID: 26400151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Patients.
    He Q; Li H; Rui Y; Liu L; He B; Shi Y; Su X
    Clin Infect Dis; 2018 Jan; 66(2):261-267. PubMed ID: 29020397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum PAI-1 and PAI-1 4G/5G Polymorphism in Hepatitis C Virus-Induced Cirrhosis and Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients.
    El Edel RH; Essa ES; Essa AS; Hegazy SA; El Rowedy DI
    Viral Immunol; 2016 Nov; 29(9):510-515. PubMed ID: 27459171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients.
    Feder S; Haberl EM; Spirk M; Weiss TS; Wiest R; Buechler C
    Clin Exp Med; 2020 May; 20(2):289-297. PubMed ID: 32078718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-related hepatocellular carcinoma and liver cirrhosis.
    Pecic V; Stankovic-Djordjevic D; Nestorovic M; Radojkovic M; Marjanovic H; Ilic B; Milojkovic M
    J BUON; 2011; 16(2):277-81. PubMed ID: 21766498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
    Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C.
    Gorka-Dynysiewicz J; Pazgan-Simon M; Zuwala-Jagiello J
    Biomed Res Int; 2019; 2019():2639248. PubMed ID: 31061822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
    Helaly GF; Abou Shamaa LA
    Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
    Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
    Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGE.
    Ferrín G; Ranchal I; Llamoza C; Rodríguez-Perálvarez ML; Romero-Ruiz A; Aguilar-Melero P; López-Cillero P; Briceño J; Muntané J; Montero-Álvarez JL; De la Mata M
    Liver Int; 2014 Mar; 34(3):438-46. PubMed ID: 23944848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
    Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
    J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
    Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
    J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin 3 Genetic Variants and The Risk of Active Pulmonary Tuberculosis.
    Sheneef A; Hussein MT; Mohamed T; Mahmoud AA; Yousef LM; Alkady OA
    Egypt J Immunol; 2017 Jan; 24(1):21-27. PubMed ID: 29120574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
    Kerget F; Kerget B; Kahraman ÇY; Araz Ö; Akgün M; Uçar EY; Sağlam L
    J Med Virol; 2021 Dec; 93(12):6653-6659. PubMed ID: 34314051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.